Cutaneous T-cell lymphomas.
D000287:Administration, Topical; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D004583:Electrons; D005260:Female; D011564:Furocoumarins / Q000627:therapeutic use; D006801:Humans; D007111:Immunity, Cellular; D007223:Infant; D008198:Lymph Nodes / Q000473:pathology; D008223:Lymphoma / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D008297:Male; D008466:Mechlorethamine / Q000008:administration & dosage; D008875:Middle Aged; D010778:Photochemotherapy; D011379:Prognosis; D012878:Skin Neoplasms / Q000473:pathology; D013601:T-Lymphocytes / Q000276:immunology*; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
D000970:Antineoplastic Agents; D011564:Furocoumarins; D008466:Mechlorethamine